Immuno-oncology in the perioperative setting: the next frontier in resectable head and neck cancers - a systematic review
This systematic review was triaged for T6 - Novel Therapeutics (immunotherapy/CAR-T) based on abstract review. It appears standard priority because it addresses a direct clinical or diagnostic question with stronger evidence maturity.
This systematic review was triaged for T6 - Novel Therapeutics (immunotherapy/CAR-T) based on abstract review. It appears standard priority because it addresses a direct clinical or diagnostic question with stronger evidence maturity.
What the study was
- Study design
- Systematic review
- Maturity
- Validated
- Journal
- BMC cancer
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.